The key to accelerating your drug development program?
Our award-winning bfLEAP™ explainable AI platform.
Developed at the prestigious Johns Hopkins University Applied Physics Laboratory and exclusively licensed to BullFrog AI for use in the drug development industry, bfLEAP™ is engineered to usher in the next generation of precision medicines.
Applications of bfLEAP™
Harness the transformative power of artificial intelligence to unravel the stories hidden in your data. At its core, the bfLEAP™ platform is designed with a keen focus on biological and clinical data sets, creating comprehensive data networks ready for in-depth analysis. What can you uncover with our platform?
From academic data to public data sets to data from your own program, bfLEAP™ empowers you to dig deeper.
Enhancing Accuracy and Transparency With bfLEAP™
bfLEAP™ is a comprehensive platform for professionals seeking to derive actionable insights from their data, ensuring clarity, efficiency, and precision at every step of the process.
Why bfLEAP™ Stands Out: Explainable AI
At the heart of bfLEAP™’s design is a commitment to Explainable AI. In the field of healthcare, understanding the “why” behind analytical outcomes is a necessity.
- Ensuring ethical research and development practices
- Making informed decisions based on AI results
- Gaining trust and confidence in the AI recommendations
bfLEAP™ Model Highlight: Pioneering Anomaly Detection via Random Subspace Mixture Models
Anomaly detection plays a pivotal role in ensuring accurate and insightful data interpretation — particularly in the fields of biology and clinical research — making RSMM anomaly detection one of the most important algorithms integrated into the bfLEAP™ platform. By leveraging the power of Gaussian Mixture Models (GMMs), RSMM efficiently and accurately represents subspaces in data graphs.